October 15, 2025 · Form 4 insider transaction
Gollob Jared bought 22,210 shares of Kymera Therapeutics, Inc. at $2.08 per share, a transaction worth $46.2K. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 0 days after the transaction.
These transactions were effected pursuant to a Rule 10b5-1 trading plan dated June 2, 2025 adopted by the reporting person.